Nils Idar Glenjen

机构：Haukeland University Hospital

发表论文 29 篇 · 总被引 2507 次 · h-index 15

代表论文

• Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial (2018 · The Lancet · 被引 1339)
• A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction (2016 · Annals of Oncology · 被引 403)
• Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial (2018 · Diseases of the Esophagus · 被引 166)
• Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer (2018 · Journal of Translational Medicine · 被引 141)
• Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. (2004 · PubMed · 被引 85)
• In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8 (2004 · Leukemia Research · 被引 70)